Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Emroy University
mi
from
Atlanta, GA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Helen DeVos Children's Hospital
mi
from
Grand Rapids, MI
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Helen DeVos Children's Hospital
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Nemours/Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Nemours/Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Seattle Children's Hospital, Research, and Foundation
mi
from
Seattle, WA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Seattle Children's Hospital, Research, and Foundation
mi
from
Seattle, WA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Stanford University
mi
from
Stanford, CA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Stony Brook Long Island Children's Hospital
mi
from
Stony Brook, NY
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Stony Brook Long Island Children's Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Texas Children's Hospital
mi
from
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Iowa
mi
from
Des Moines, IA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Iowa
mi
from
Des Moines, IA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Michigan
mi
from
Ann Arbor, MI
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of New Mexico
mi
from
Albuquerque, NM
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Vanderbilt University
mi
from
Nashville, TN
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Virginia Commonwealth University
mi
from
Richmond, VA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Washington University
mi
from
St. Louis, MO
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Yale University
mi
from
New Haven, CT
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Status: Enrolling
Updated:  6/30/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Status: Enrolling
Updated: 6/30/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Advanced Arizona Clinical Research
mi
from
Tucson, AZ
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Advanced Arizona Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Richard Cherlin, MD
mi
from
Los Gatos, CA
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Richard Cherlin, MD
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
The Endocrine Medical Group, Inc.
mi
from
Orange, CA
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
The Endocrine Medical Group, Inc.
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Clinical Research of South Florida
mi
from
Coral Gables, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
The Center for Diabetes and Endocrine Care
mi
from
Hollywood, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
The Center for Diabetes and Endocrine Care
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Coral Research Clinic
mi
from
Miami, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Coral Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Volunteer Medical Research
mi
from
Port Charlotte, FL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Volunteer Medical Research
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Creighton Diabetes Center
mi
from
Omaha, NE
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Creighton Diabetes Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
LLC DBA AccessMD Clinical Research
mi
from
Dayton, OH
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
LLC DBA AccessMD Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Harold Hamm Diabetes Center
mi
from
Oklahoma City, OK
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Harold Hamm Diabetes Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
SC Nephrology & Hypertension Ctr
mi
from
Orangeburg, SC
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
SC Nephrology & Hypertension Ctr
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
17070 Red Oak dr Ste 103
mi
from
Houston, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
17070 Red Oak dr Ste 103
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
West Houston Clinical Research Services (WHCRS)
mi
from
Houston, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
West Houston Clinical Research Services (WHCRS)
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  7/1/2014
Dialysis West University Health System
mi
from
San Atonio, TX
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 7/1/2014
Dialysis West University Health System
mi
from
San Atonio, TX
Click here to add this to my saved trials
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Status: Enrolling
Updated:  7/26/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
Status: Enrolling
Updated: 7/26/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
Anaheim, CA
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
DeLand, FL
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
South Miami, FL
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
St. Paul, MN
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Louisville, KY
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Milwaukee, WI
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Chicago, IL
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
St. Louis, MO
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Livingston, NJ
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Livingston, NJ
Click here to add this to my saved trials
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated:  8/18/2014
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Status: Enrolling
Updated: 8/18/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials